Adrian Adams, Director at ACELRX PHARMACEUTICALS INC (ACRX), bought 75,000 shares at $8.39 ($614K) on 2013-05-28, disclosed to the SEC on 2013-05-29.
Open-market purchase of $614k ACRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.78 | 25,000 | $195K | 31.7% |
| 2 | $8.39 | 50,000 | $420K | 68.3% |
| Total | $8.19 avg | 75,000 | $614K | 100% |
| Filing → |
| AKBA | BUY | 2019-11-21 | $171K | — | Filing → |
| ARLZ | BUY | 2017-03-17 | $1.2M | — | Filing → |
| POZN | BUY | 2015-11-12 | $6.6M | — | Filing → |